Mutational analysis of CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer Meeting Abstract
| Authors: | Hoadley, K. A.; Barry, W. T.; Pitcher, B. N.; Parker, J. S.; Wilkerson, M. D.; Irvin, W.; Henry, N. L.; Tolaney, S. M.; Dang, C.; Krop, I. E.; Berry, D. A.; Mardis, E. R.; Perou, C. M.; Winer, E. P.; Hudis, C. A.; Carey, L. A. |
| Abstract Title: | Mutational analysis of CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer |
| Meeting Title: | 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 75 |
| Issue: | 9 Suppl. |
| Meeting Dates: | 2014 Dec 9-13 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2015-05-01 |
| Language: | English |
| ACCESSION: | WOS:000356730200023 |
| DOI: | 10.1158/1538-7445.sabcs14-s3-06 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: S3-06 -- 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium -- DEC 09-13, 2014 -- San Antonio, TX -- S -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
